Tags

Type your tag names separated by a space and hit enter

British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.
Gut. 2020 02; 69(2):201-223.Gut

Abstract

These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorectal imaging in people aged 18 years and over. They are the first guidelines that take into account the introduction of national bowel cancer screening. For the first time, they also incorporate surveillance of patients following resection of either adenomatous or serrated polyps and also post-colorectal cancer resection. They are primarily aimed at healthcare professionals, and aim to address:Which patients should commence surveillance post-polypectomy and post-cancer resection?What is the appropriate surveillance interval?When can surveillance be stopped? two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument provided a methodological framework for the guidelines. The BSG's guideline development process was used, which is National Institute for Health and Care Excellence (NICE) compliant.two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The key recommendations are that the high-risk criteria for future colorectal cancer (CRC) following polypectomy comprise either:two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps This cohort should undergo a one-off surveillance colonoscopy at 3 years. Post-CRC resection patients should undergo a 1 year clearance colonoscopy, then a surveillance colonoscopy after 3 more years.

Authors+Show Affiliations

Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK matt.rutter@nth.nhs.uk. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK. Gastroenterology, South Tyneside NHS Foundation Trust, South Shields, UK.Western Sussex Hospitals NHS Foundation Trust, Chichester, UK.Colorectal surgery, Raigmore Hospital, Inverness, UK.Gastroenterology, Cardiff and Vale NHS Trust, Cardiff, UK.Histopathology, Nottingham University Hospitals, Nottingham, UK.Family History of Bowel Cancer Clinic, West Middlesex University Hospital, London, UK. Imperial College, London, UK.Histopathology, University College London, London, UK.Centre for Medical Imaging, UCL, London, UK.Endoscopy, St Marks Hospital, London, UK.Wolfson Unit for Endoscopy, St Mark's Hospital, London, UK.Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.Gastroenterology, University Hospital of Hartlepool, Hartlepool, UK.School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.London, UK.London, UK.Cancer Screening, Public Health England, London, UK.Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine of Imperial College, Imperial College London, London, UK.Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.

Pub Type(s)

Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31776230

Citation

Rutter, Matthew D., et al. "British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England Post-polypectomy and Post-colorectal Cancer Resection Surveillance Guidelines." Gut, vol. 69, no. 2, 2020, pp. 201-223.
Rutter MD, East J, Rees CJ, et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut. 2020;69(2):201-223.
Rutter, M. D., East, J., Rees, C. J., Cripps, N., Docherty, J., Dolwani, S., Kaye, P. V., Monahan, K. J., Novelli, M. R., Plumb, A., Saunders, B. P., Thomas-Gibson, S., Tolan, D. J. M., Whyte, S., Bonnington, S., Scope, A., Wong, R., Hibbert, B., Marsh, J., ... Sharp, L. (2020). British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut, 69(2), 201-223. https://doi.org/10.1136/gutjnl-2019-319858
Rutter MD, et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England Post-polypectomy and Post-colorectal Cancer Resection Surveillance Guidelines. Gut. 2020;69(2):201-223. PubMed PMID: 31776230.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. AU - Rutter,Matthew D, AU - East,James, AU - Rees,Colin J, AU - Cripps,Neil, AU - Docherty,James, AU - Dolwani,Sunil, AU - Kaye,Philip V, AU - Monahan,Kevin J, AU - Novelli,Marco R, AU - Plumb,Andrew, AU - Saunders,Brian P, AU - Thomas-Gibson,Siwan, AU - Tolan,Damian J M, AU - Whyte,Sophie, AU - Bonnington,Stewart, AU - Scope,Alison, AU - Wong,Ruth, AU - Hibbert,Barbara, AU - Marsh,John, AU - Moores,Billie, AU - Cross,Amanda, AU - Sharp,Linda, Y1 - 2019/11/27/ PY - 2019/09/17/received PY - 2019/10/14/revised PY - 2019/10/15/accepted PY - 2019/11/30/pubmed PY - 2020/1/30/medline PY - 2019/11/29/entrez KW - colonic polyps KW - colonoscopy KW - colorectal adenomas KW - colorectal cancer KW - surveillance SP - 201 EP - 223 JF - Gut JO - Gut VL - 69 IS - 2 N2 - These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorectal imaging in people aged 18 years and over. They are the first guidelines that take into account the introduction of national bowel cancer screening. For the first time, they also incorporate surveillance of patients following resection of either adenomatous or serrated polyps and also post-colorectal cancer resection. They are primarily aimed at healthcare professionals, and aim to address:Which patients should commence surveillance post-polypectomy and post-cancer resection?What is the appropriate surveillance interval?When can surveillance be stopped? two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument provided a methodological framework for the guidelines. The BSG's guideline development process was used, which is National Institute for Health and Care Excellence (NICE) compliant.two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The key recommendations are that the high-risk criteria for future colorectal cancer (CRC) following polypectomy comprise either:two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps This cohort should undergo a one-off surveillance colonoscopy at 3 years. Post-CRC resection patients should undergo a 1 year clearance colonoscopy, then a surveillance colonoscopy after 3 more years. SN - 1468-3288 UR - https://www.unboundmedicine.com/medline/citation/31776230/British_Society_of_Gastroenterology/Association_of_Coloproctology_of_Great_Britain_and_Ireland/Public_Health_England_post-polypectomy_and_post-colorectal_cancer_resection_surveillance_guidelines L2 - http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=31776230 DB - PRIME DP - Unbound Medicine ER -